Forte Biosciences Statistics
Total Valuation
FBRX has a market cap or net worth of $527.57 million. The enterprise value is $469.34 million.
Important Dates
The last earnings date was Monday, May 11, 2026, before market open.
| Earnings Date | May 11, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
FBRX has 24.44 million shares outstanding. The number of shares has increased by 236.82% in one year.
| Current Share Class | 20.48M |
| Shares Outstanding | 24.44M |
| Shares Change (YoY) | +236.82% |
| Shares Change (QoQ) | +0.03% |
| Owned by Insiders (%) | 1.80% |
| Owned by Institutions (%) | 58.63% |
| Float | 18.83M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 9.16 |
| P/TBV Ratio | 12.53 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.75
| Current Ratio | 2.75 |
| Quick Ratio | 2.49 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -188.40% and return on invested capital (ROIC) is -119.48%.
| Return on Equity (ROE) | -188.40% |
| Return on Assets (ROA) | -83.90% |
| Return on Invested Capital (ROIC) | -119.48% |
| Return on Capital Employed (ROCE) | -176.64% |
| Weighted Average Cost of Capital (WACC) | 20.77% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$3.99M |
| Employee Count | 19 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, FBRX has paid $1.41 million in taxes.
| Income Tax | 1.41M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +203.02% in the last 52 weeks. The beta is 3.00, so FBRX's price volatility has been higher than the market average.
| Beta (5Y) | 3.00 |
| 52-Week Price Change | +203.02% |
| 50-Day Moving Average | 26.86 |
| 200-Day Moving Average | 21.70 |
| Relative Strength Index (RSI) | 38.38 |
| Average Volume (20 Days) | 221,618 |
Short Selling Information
The latest short interest is 1.04 million, so 4.24% of the outstanding shares have been sold short.
| Short Interest | 1.04M |
| Short Previous Month | 843,652 |
| Short % of Shares Out | 4.24% |
| Short % of Float | 5.51% |
| Short Ratio (days to cover) | 2.62 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -76.97M |
| Pretax Income | -74.45M |
| Net Income | -75.86M |
| EBITDA | -76.90M |
| EBIT | -76.97M |
| Earnings Per Share (EPS) | -$4.25 |
Full Income StatementBalance Sheet
The company has $58.22 million in cash and n/a in debt, with a net cash position of $58.22 million or $2.38 per share.
| Cash & Cash Equivalents | 58.22M |
| Total Debt | n/a |
| Net Cash | 58.22M |
| Net Cash Per Share | $2.38 |
| Equity (Book Value) | 42.10M |
| Book Value Per Share | 2.36 |
| Working Capital | 41.46M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$59.34 million and capital expenditures -$55,000, giving a free cash flow of -$59.39 million.
| Operating Cash Flow | -59.34M |
| Capital Expenditures | -55,000 |
| Depreciation & Amortization | 70,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -59.39M |
| FCF Per Share | -$2.43 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
FBRX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -236.82% |
| Shareholder Yield | -236.82% |
| Earnings Yield | -14.38% |
| FCF Yield | -11.26% |
Analyst Forecast
The average price target for FBRX is $63.75, which is 195.89% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $63.75 |
| Price Target Difference | 195.89% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on August 28, 2024. It was a reverse split with a ratio of 1:25.
| Last Split Date | Aug 28, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:25 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |
